Release Connecticut’s Prisoners? Health Experts, Activists Urge “Decarceration” to Slow Pandemic
Members of the Yale and local activist communities are coming together to urge Connecticut Gov. Ned Lamont to depopulate the state’s prisons to combat the spread of COVID-19 and protect the state’s most vulnerable populations from the pandemic.
Low HIV transmission among recently incarcerated individuals living with HIV and SUDs
An assessment of sexual risk behaviors, as they relate to viral suppression, from before, during and after incarceration among persons living with HIV and alcohol use or opioid use disorders demonstrated that the risk of HIV transmission among this population is low.Source: Healio
$5.5 Million Grant Supports Study of Model to Integrate Treatments for Opioid Addiction, Infectious Diseases
As part of a multi-site collaboration involving principal investigators from Columbia University, Medical University of South Carolina (MUSC), and University of South Carolina School of Medicine-Greenville, Yale’s Dr. Sandra Springer will study a new model of treatment for opioid addiction. The investigation is supported by a grant from the National Center for Advancing Translational Sciences.
Opioid Use Disorder Should Be Thought of Like an Infectious Disease, Experts Say
Opioid use disorder (OUD) is not an infectious disease, but a new paper from the National Institutes of Health (NIH) and the University of Maryland argues that ID specialists need to start considering themselves as a first line of treatment against the disorder.Source: Contagion Live
After Prison, Many People Living With HIV Go Without Treatment
When people living with HIV walk out of prison, they leave with up to a month's worth of HIV medication in their pockets. What they don't necessarily leave with is access to health care or the services that will keep them healthy in the long term.Source: NPR
High rates of HIV and diabetes raise the risk of TB for South Africans
Since the 1980s, HIV has contributed to an increase in tuberculosis (TB) cases across the globe. Recently, diabetes has been found to be an important risk factor for TB. In a new study, Yale researchers investigated whether having both HIV and diabetes increases the risk of developing TB among individuals living in rural South Africa.
Hepatitis C ‘treatment as prevention’ strategy examined in new study
Hepatitis C infection is a global phenomenon that affects millions worldwide, with an estimated 30,500 new cases in the United States alone each year. Expanding treatment, however, could go a long way toward preventing transmission of the virus among high-risk individuals who inject drugs, according to new Yale-led research.
GHLI announces junior faculty awards
The Yale Global Health Leadership Institute (GHLI) announced this year’s recipients of the Hecht-Albert Pilot Innovation Award for Junior Faculty. The award is granted to junior faculty who engage students to advance new research and educational projects in global health at Yale.
Yale Welcomes Malaysian HIV Scientist to Campus
Yale Clinical and Community Research is pleased to welcome Malaysian HIV physician-scientist, Dr. Iskandar Azwa, to campus as a 2017 International Visiting Fellow. Dr. Azwa is an Associate Professor of infectious diseases at the University of Malaya in Kuala Lumpur where he is leading efforts to scale-up biomedical approaches to HIV prevention among key populations, including men who have sex with men and other sexual and gender minority groups. Dr. Azwa's visit is sponsored by Yale's Center for Interdisciplinary Research on AIDS (CIRA).
Yale Students Work with Local Teens to Promote Careers in Health, Medicine
Odalys Hernandez, a junior at the Metropolitan Business Academy in New Haven, has long dreamed of a career in medicine. “But when people talked about what I might do, it was always just doctors or nurses,” she said. “I knew there had to be more.”
In Malaysian prison, Aishwarya Vijay gains greater insight into the problem of addiction
Recent Yale College graduate Aishwarya Vijay ’14 had never set foot in a prison until she traveled to Malaysia, where her work this summer allowed her to learn about the sometimes subtle connections between stigma and treatment-seeking behavior in injection-drug-using prisoners.
HIV-infected women experience worse treatment outcomes after release from jail
A Yale study has uncovered significant gender differences in the treatment outcomes of HIV-infected jail detainees who are transitioning to life outside jail, with women faring much worse than men. The study appears online in the American Journal of Public Health.